Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background/Aims: The usefulness of immunohistochemistry to screen for the microsatellite instability (MSI) phenotype in gastric cancer remains unclear. Moreover, the prognostic value of MSI phenotypes in gastric cancer has been debated. Methods: The clinicopathologic parameters and survival outcomes of 203 MSI-high (MSI-H) and 261 microsatellite-stable (MSS) advanced gastric cancers (AGCs) were compared. Next, we compared the immunohistochemistry results for hMLH1 and hMSH2 with those of a polymerase chain reaction (PCR)-based method. Kaplan-Meier curves and a Cox proportional hazard regression model were used to conduct survival analyses. Results: The MSI-H AGCs were correlated with older age (p<0.001), female gender (p=0.018), distal location (p<0.001), larger size (p=0.016), and intestinal type (p<0.001). Multivariate analysis revealed that the MSI-H phenotype was an independent favorable factor that was related to overall survival in patients with AGC (p<0.001). Compared with the PCR-based analysis, immunohistochemistry exhibited high sensitivity (91.1%) and specificity (98.5%) in the detection of MSI phenotypes. Conclusions: MSI-H gastric cancers have distinct clinicopathologic features and better prognoses, which suggests the necessity of MSI analysis in gastric cancer. Immunohistochemistry can be a useful and reliable screening method in the assessment of MSI status in gastric cancer.
Abstract
Background/Aims: The usefulness of immunohistochemistry to screen for the microsatellite instability (MSI) phenotype in gastric cancer remains unclear. Moreover, the prognostic value of MSI phenotypes in gastric cancer has been debated. Methods: The clinicopathologic parameters and survival outcomes of 203 MSI-high (MSI-H) and 261 microsatellite-stable (MSS) advanced gastric cancers (AGCs) were compared. Next, we compared the immunohistochemistry results for hMLH1 and hMSH2 with those of a polymerase chain reaction (PCR)-based method. Kaplan-Meier curves and a Cox proportional hazard regression model were used to conduct survival analyses. Results: The MSI-H AGCs were correlated with older age (p<0.001), female gender (p=0.018), distal location (p<0.001), larger size (p=0.016), and intestinal type (p<0.001). Multivariate analysis revealed that the MSI-H phenotype was an independent favorable factor that was related to overall survival in patients with AGC (p<0.001). Compared with the PCR-based analysis, immunohistochemistry exhibited high sensitivity (91.1%) and specificity (98.5%) in the detection of MSI phenotypes. Conclusions: MSI-H gastric cancers have distinct clinicopathologic features and better prognoses, which suggests the necessity of MSI analysis in gastric cancer. Immunohistochemistry can be a useful and reliable screening method in the assessment of MSI status in gastric cancer.
참고문헌 (19)
- Kim H, "Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences", Am J Pathol, 145, pp.148~156 (1994)
- Gryfe R, "Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer", N Engl J Med, 342, pp.69~77 (2000)
- Lee HS, "Distinct clinical features and outcomes of gastric cancers with microsatellite instability", Mod Pathol, 15, pp.632~640 (2002)
- Beghelli S, "Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers", Surgery, 139, pp.347~356 (2006)
- Kim H, "High microsatellite instability predicts good prognosis in intestinal-type gastric cancers", J Gastroenterol Hepatol, 26, pp.585~592 (2011)
- Seo HM, "Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype", J Surg Oncol, 99, pp.143~147 (2009)
- Falchetti M, "Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival", Hum Pathol, 39, pp.925~932 (2008)
- Fang WL, "Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery", World J Surg, 36, pp.2131~2138 (2012)
- Chaves P, "Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype", J Pathol, 191, pp.355~360 (2000)
- Lindor NM, "Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors", J Clin Oncol, 20, pp.1043~1048 (2002)
- Jourdan F, "Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression", Virchows Arch, 443, pp.115~121 (2003)
- Hendriks Y, "Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors", Am J Pathol, 162, pp.469~477 (2003)
- Bosman FT, "WHO classification of tumours of the digestive system" (2010), International Agency for Research on Cancer
- Lauren P, "The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification", Acta Pathol Microbiol Scand, 64, pp.31~49 (1965)
- Edge SB, "AJCC cancer staging manual" (2010), Springer
- Umar A, "Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability", J Natl Cancer Inst, 96, pp.261~268 (2004)
- Shin Hyuk Kim, "Microsatellite Instability Is Associated with the Clinicopathologic Features of Gastric Cancer in Sporadic Gastric Cancer Patients", Journal of Gastric Cancer, 10(4), pp.149~154 (2010), 대한위암학회
- Shia J, "The utility of immunohistochemical detection of DNA mismatch repair gene proteins", Virchows Arch, 445, pp.431~441 (2004)
- de Jong AE, "Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer", Clin Cancer Res, 10, pp.972~980 (2004)